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Interleukin-11 (IL-l 1) is known to be a member of the interleukin-6 (IL-6)-type cytokine family. IL-l 1 is likely to 
be a major determinant of immune regulation in acute and chronic inflammatory lung diseases, although it is not 
directly linked with specific disease processes. It has already been shown that although unstimulated human lung 
fibroblasts did not produce significant amounts of IL- 11, the addition of interleukin- lcr (IL- ICC) and/or transforming 
growth factor-p (TGF-/?) stimulated fibroblasts dose-dependently to produce IL-l 1. Northern blot analysis showed 
that these stimulators also upregulated IL-l 1 mRNA expression. As it has been previously reported that IL-l and 
TGF-fi stimulate prostaglandin E2 (PGE2) release from lung fibroblasts, we investigate here the role of endogenous 
PGEz and the direct effects of the two inhibitors of prostaglandin synthesis, indomethacin and dexamethasone, on 
IL-l 1 production by human lung fibroblasts. The addition of indomethacin, a cycle-oxygenase inhibitor, resulted in 
significant suppression of IL-11 production and mRNA expression in lung fibroblasts. There was no detectable 
effect of PGE, alone on IL-11 levels; however, the suppression of IL-11 production by indomethacin was almost 
completely reversed by addition of PGE2. In contrast, suppression of IL-1 1 production by indomenthacin was not 
reversed by addition of thromboxane B2 and carbocyclic thromboxane AZ. In addition, dexamethasone completely 
suppressed IL-l 1 production and downregulated IL-l 1 mRNA. These results suggest that endogenous PGEz acts 
as an autocrine stimulus for IL-11 production by human lung fibroblasts activated by IL-la and TGF-fi. 
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Introduction 
Macrophage/monotype-derived cytokines, including inter- 
leukin-1 (IL-l), tumour necrosis factor (TNF) and trans- 
forming growth factor-p (TGF-I), have been shown to be 
important contributors to the inflammatory and fibrotic 
processes of the lung (1,2). Recent data have suggested that 
the local stromal cell population, such as lung fibroblasts, is 
also a significant contributor to the local cytokine pool 
which causes inflammatory and fibrotic responses in airway 
disorders (3). Interleukin-6 (IL-6), interleukin-8 (IL-8), 
granulocyte-macrophage colony stimulating factor (GM- 
CSF) and granulocyte-CSF (G-CSF) are all major products 
of lung fibrobalsts and are found in various inflamed tissues 
(3-5). 
Interleukin-1 1 (IL-l 1) was originally identified from the 
primate bone marrow-derived stromal cell line, PU-34, 
based on its ability to stimulate the proliferation of IL-6- 
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dependent cells (6). In accordance with this finding, most 
studies on IL-1 1 have focused on its roles in haematopoiesis 
(7-9). However, IL-11 has other bioactivities such as the 
induction of acute phase protein production (lo), B-cell 
activation (11) and augmentation of the production of 
metalloproteinase inhibitor (12). Recent studies have also 
demonstrated that IL-l 1 has protective effects in a number 
of animal models of acute and chronic inflammation or 
injury (13-15). This protection is due, at least in part, to the 
ability of IL-1 1 to regulate the production of pro- 
inflammatory cytokines and nitric oxide by macrophages 
(13, 15). Since lung stromal cells have the ability to produce 
IL-11 in response to various stimuli (16, 17) IL-11 may 
have an important role in the modulation of inflammatory 
and fibrotic responses in human lung disorders. 
The products of the cycle-oxygenase pathway, such as 
prostaglandin Ez (PGE& also participate in inflammatory 
responses (18). An inhibitory effect of PGE2 on immune cell 
function has been documented. PGEz can inhibit the release 
of IL-l and TNF from myeloid cells (19). In addition, 
Hamilton et al. showed that fibroblast-derived colony 
stimulating factors were modulated by endogenous and 
exogenous prostanoids (20). Therefore, a link between 
PGEz and stromal cell cytokine production appears to be 
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evident. We have previously demonstrated that freshly 
prepared rheumatoid synovial cells produced large amounts 
of IL-11 and the production of IL-11 by fresh rheumatoid 
synovial cells was regulated by PGE2 (21). However, the 
regulation of IL-11 expression in freshly isolated human 
lung fibroblasts has not been clarified. Thus, in this study, 
we investigated the role of endogenous PGE2 and the direct 
effects of the two inhibitors of prostaglandin synthesis, 
indomethacin and dexamethasone, on IL-l 1 production by 
human lung fibroblasts. 
Materials and Methods 
MATERIALS 
Human recombinant IL-la was kindly provided by 
Dainippon Pharmaceutical Co. (Osaka, Japan). Recombi- 
nant TGF-Pi was purchased from R&D Systems (Minnea- 
polis, MN, U.S.A.). PGE2, thromboxane B2 and 
carbocyclic thromboxane A2 were purchased from Cayman 
Chemical Co. (Ann Arbor, MI, U.S.A.). Indomethacin and 
dexamethasone were purchased from Wako Pure Chemical 
Industries Ltd. (Osaka, Japan). Dulbecco’s modified 
Eagle’s medium (DMEM) and phosphate-buffered saline 
(PBS(-)) were purchased from Nissui Pharmaceutical Co. 
(Tokyo, Japan). 
CELL PREPARATION 
Human lung tissues were obtained from lungs of patients 
undergoing lobectomy because of lung cancer. The normal 
part of the lobe was washed with PBS and the pleural 
tissues and bronchi were removed after resection. Human 
lung fibroblasts were prepared as previously described (22). 
Briefly, specimens were minced and enzymatically digested 
with 0.5-l .O mg ml-’ clostridium collagenase (Wako Pure 
Chemical Industries) and 5-10 mg ml-’ deoxyribonuclease 
1 (Sigma Chemical Co. St. Louis, MO, U.S.A.) for 2-3 h. 
After digestion, the single cells were filtrated through gauze, 
washed three times with DMEM and filtered through nylon 
mesh. The cells were resuspended in complete medium 
[DMEM supplemented with 10% heat-inactivated fetal calf 
serum (FCS), 100 U ml-’ penicillin G, 50 mg ml-’ 
streptomycin, 2 mM L-glutamine and non-essential amino 
acids (GIBCO BRL, Gland Island, NY, U.S.A.)]. The cells 
were cultured overnight to adhere to a plastic dish. The dish 
was washed to remove non-adherent cells. After three to 
four passages, fibroblasts were used as freshly isolated 
human lung fibroblasts and grown to confluence in 5% 
Co2/95% air in complete medium. 
LUNG FIBROBLAST CULTURE 
Lung fibroblasts were treated with typsin and plated at a 
density of 2 x lo5 cells per well in 24-well flat-bottom plates. 
To examine whether treatment of freshly isolated human 
lung fibroblasts with IL-la and/or TGF-P might modulate 
their production of IL-l 1 or PGEs, the cells were incubated 
with various concentrations of IL-la and/or TGF-P for the 
time indicated. After incubation, the cell-free culture 
supernatants were stored at -20°C until assay for IL-11 
or PGE2. 
To examine the role of endogenous PGEz on IL-la and 
TGF-P-induced IL-1 1 production, lung fibroblasts were 
incubated with IL-lx and TGF-/I in the presence and 
absence of 1O-5 M indomethacin or 10e6 M dexamethasone 
for 24 h. After incubation, the cell-free culture supernatants 
were stored at -20°C until assay for IL-I 1. 
MEASUREMENT OF IL-11 PROTEIN AND 
PROSTAGLANDIN E2 
IL-11 protein was measured with an ELISA assay kit 
(Quantikine TM human IL-l 1 ELISA kit; R&D Systems). 
PGEz was measured with ELISA assay kit purchased from 
Neogen TM corporation (Lexington, KY, U.S.A.). 
mRNA ISOLATION AND ANALYSIS 
Lung fibroblasts were incubated with IL-la and/or TGF-P 
for 24 h in the presence and absence of 1O-5 M indometha- 
tin or 10e6 M dexamethasone. Total celluiar RNA in the 
treated cells was extracted by acid guanadinium thiocya- 
nate-phenol-chloroform extraction method using ISOGEN 
(Nippon Gene, Tokyo, Japan), and Northern blot analysis 
was carried out as previously described (22). Fifteen 
micrograms of total RNA from each experimental condi- 
tion was size fractionated by electrophoresis through 1% 
agarose /17% formaldehyde gels, transferred to nylon 
membranes (Amersham, Tokyo, Japan) and hybridized 
with digoxigenin-labelled cDNA probes (Boehringer Man- 
nheim, Germany). IL-11 cDNA was a gift of Dr Paul 
Schendel (Genetics Institute, Cambridge, MA, U.S.A.). The 
intensity of the band was analysed by National Institute of 
Health (NIH) Image software. 
STATISTICAL ANALYSIS 
Values are presented as the mean +(SEM). Data were 
analysed by a Student’s t-test. P-values less than 0.05 were 
considered as statistically significant. 
Results 
As shown in Fig. 1, lung fibroblasts produced a trace 
amount of IL-11 without stimuli. IL-la or TGF-j 
stimulated lung fibroblasts to produce IL-11 in a dose- 
dependent manner [Fig. l(a,b)]. Incubation with both 
cytokines resulted in higher IL-11 production than with 
either cytokine alone [Fig. l(c)]. 
As shown in Fig. 2, the amounts of IL-11 production in 
response to IL-la and TGF-P increased in a time- 
dependent manner, and reached a maximum at 24 h. 
As shown in Fig. 3, unstimulated lung fibroblasts 
produced a trace amount of PGE2. A low level of PGEz 
production was detectable under TGF-P stimulation, while 
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FIG. 1. Effect of IL-lx and TGF-1 on IL-l 1 production by freshly isolated human lung tibroblasts. Cells were incubated with 
various concentrations of IL-lol (a), TGF-/3 (b) or 1.0 ng ml-‘IL-la plus 5.0 ng ml-‘TGF-P (c) for 24 h. IL-11 was 
measured by ELISA in the supernatant. Data are expressed as mean +SEM of at least three independent experiments. 
*P<O.O5 VS. the medium control; **P<O.Ol vs. the medium control; #P<O.O05 vs. the medium control; ##P<O*OOl vs. the 
medium control. 
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FIG. 2. Time course of IL-la and TGF-P-induced IL-l 1 
production by freshly isolated human lung fibroblasts. 
Cells were incubated with 1.0 ng ml-’ IL-lc( plus 5.0 ng 
m - ’ TGF-fi for the time indicated, and IL-l 1 was 
measured by ELISA in the supernatants. Data are 
expressed as mean + SEM of three independent 
experiments. 
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FIG. 3. Effect of IL- 1 cI and TGF-/3 on PGEz production by 
freshly isolated human lung fibroblasts. Cells were 
incubated with 1.0 ng ml-’ IL-la and/or 5.0 ng 
ml-‘TGF-P for 24 h. PGE2 was measured by ELISA in 
the supernatants. Data are expressed as mean ~SEM of 
four independent experiments. *P<O.O5 vs. the medium 
control: **P<O.Ol vs. the medium control. 
a significant increase in PGEz level was detectable after 
IL-la stimulation. Incubation with both cytokines resulted 
in higher PGEz production than with either cytokine alone 
(Fig. 3). 
As shown in Fig. 4, the production of IL-11 was 
significantly inhibited by indomethacin. In addition, 
dexamethasone completely inhibited IL-I 1 production 
(Fig. 4). 
The levels of IL-11 mRNA expressed by unstimulated 
cells were extremely low, while a significant increase in IL- 
11 mRNA levels was observed upon stimulation with 
1.0 ng ml-’ IL-la or 5.0 ngml-’ TGF-p (Fig. 5). Lung 
fibroblasts incubated with IL-la and TGF-P in combina- 
tion contained significantly higher levels of IL-11 mRNA 
than fibroblasts incubated with the cytokines individually. 
Furthermore, indomethacin inhibited IL- 1 I mRNA in 
1.0 ng ml-’ IL-la and 5.0 ng ml-’ TGF-P-stimulated lung 
tibroblasts (Fig. 5). In addition, dexamethasone suppressed 
IL-l 1 mRNA almost completely (Fig. 5). 
There were no detectable effects of PGE2 alone (data not 
shown) however, suppression of IL-11 production by 
indomethacin was reversed almost completely by addition 
of exogenous PGE2 (Fig. 6). In contrast, the suppression of 
IL-11 production by indomethacin was not reversed by 
addition of thromboxane B2 and carbocyclic thromboxane 
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FIG. 4. Inhibitory effects of indomethacin or 
dexamethasone on IL-lcr and TGF-P induced IL-1 1 
production by freshly isolated human lung tibroblasts. 
Cells were incubated with I.0 ng ml-’ IL-ICC and 5.0 ng 
ml-’ TGF-b in the presence and absence of lO-‘h/r 
indomethacin (IND) or 10M6~ dexamethasone (DEX) for 
24 h. IL- 11 was measured by ELISA in the supernatants. 
Data are expressed as mean f SEM of three independent 
experiments. #P<O.O05 vs. the IL-la and TGF-P 
stimulation; **P<O.OOl VS. the IL-l@ and TGF-P 
stimulation. 
AZ (data not shown). Furthermore, suppression of IL-11 
production by dexamethasone was not reversed by the 
addition of PGEz (data not shown). 
Discussion 
IL-l 1 was initially reported as a haematopoietic cytokine 
with thrombopoietic activity (7). In addition to this 
haematopoietic effects, however, it has been demonstrated 
that IL-11 protects a variety of models of tissue from 
inflammation and injury (13-15). This protection is due to 
the ability of IL-11 to regulate macrophage production of 
pro-inflammatory cytokines such as TNF and IL-l. 
Recently, Leng and Elias reported that IL-11 can also 
inhibit interleukin-12 (IL-12) production by macrophages 
(23). Excessive IL-12 production has been implicated in the 
pathogenesis of a number of diseases including sarcoidosis, 
sepsis and Sjogren’s syndrome (24-26). Lung stromal cells 
have the ability to produce IL- 11 in response to cytokines, 
such as IL-la and TGF-fl (16) and infection with some 
respiratory viruses (17). Thus IL-1 1 may have an important 
role in the modulation of inflammatory responses in lung 
disorders. 
In agreement with previous results on lung fibroblast and 
epithelial cell lines (16,17), we demonstrated that freshly 
isolated human lung fibroblasts produce immunoreactive 
IL-11 in response to IL-la and TGF-P. The stimulatory 
effect of IL-la and TGF-8 on IL-I 1 production was 
detected at the concentrations of 1 .O ng ml-’ and 
5.0 ng ml-‘, respectively. 
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FIG. 5. Inhibition of IL-lee and/or TGF-j3 induced IL-l 1 
mRNA expression in freshly isolated human lung 
fibroblasts by indomenthacin or dexamethasone. Cells 
were incubated with 1.0 ng ml-i IL-la and or 5.0 ng 
ml-” TGF-P for 24 h in the presence and absence of lo-’ 
M indomethacin (IND) or 10e6 M dexamethasone (DEX). 
Total cellular RNA was extracted, and the levels of IL-1 1 
mRNA were evaluated by Northern blot analysis. 
Densitometric ratios of IL-1 l/GAPDH are shown in 
lower panel. The data shown are the means of three 
independent experiments. 
Prostaglandin Ez is a product of the arachidonic acid 
metabolism cascade and can be synthesized by a wide range 
of cell types. Lung fibroblasts are also a source of PGE2 
during inflammatory process (27). It has been reported that 
IL-la and TGF-P stimulate PGEz synthesis in lung 
fibroblasts (28). Furthermore, PGE2 is reported to regulate 
IL-1 1 production positively in osteoblasts and synovial cells 
(21, 29). The present study showed that indomethacin 
blocked IL-la and TGF-fl induction of PGEz by human 
lung fibroblasts. It also suppressed IL-1 1 production and its 
gene expression in human lung fibroblasts. The suppression 
of IL-11 production by indomethacin was almost comple- 
tely reversed by addition of exogenous PGE2. In contrast, 
the suppression of IL-1 1 production by indomethacin was 
not reversed by the addition of thromboxane B2 and 
carbocyclic thromboxane AZ. Therefore, endogenous PGE2 
appeared to act as an autocrine stimulus for IL-1 1 
production. Our data also showed that dexamethasone 
inhibited IL-I 1 production and mRNA expression almost 
completely in IL-ICC and TGF-b stimulated lung fibroblasts. 
However, the suppression of IL-11 production by dexa- 
methasone was not reversed by the addition of PGE2. The 
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FIG. 6. Recovery of inhibitory effect of indomenthacin on 
IL-I 1 production by addition of PGE2. IL-la 
(I.0 ng ml-‘) and TGF-fi (5.0 ng ml-‘)-treated lung 
fibroblasts were incubated with 10e5 M indomethacin 
(IND) in the presence and absence of various 
concentration of PGE2. IL- 11 was measured by ELISA in 
the supernatants. Data are expressed as mean f SEM of 
three independent experiments. 
mechanisms of inhibition by dexamethasone remain to be 
clarified. It has been shown that glucocorticoids inhibit the 
induction of the gene coding for inducible cycle-oxygenase 
(COX-2) in monocytes and epithelial cells (30). However, 
glucocorticoids may not only block COX-2, but also block 
the synthesis of cytokines in several ways. Glucocorticoids 
may inhibit the synthesis of cytokine receptors, such as the 
IL-2 receptor (31). Several cytokines produce their cellular 
effects by activating transcription factors, such as AP-1 and 
NF-KB, which activate or repress target genes that are 
regulated in an opposing manner by glucocorticoid receptor 
(32). This activation is strongly inhibited by glucocorti- 
coids. As the IL-l 1 gene contains the AP-I site, which is 
known to be important for IL-11 transcription, 
in the 5’ flanking lesion (33,34), dexamethasone may 
inhibit the production of IL-11 via the inhibition of AP-1 
activity. 
In summary, we have demonstrated that IL-la and 
TGF-/I stimulated freshly isolated human lung fibroblasts 
to produce IL-11 in a dose- and time-dependent manner 
along with increased IL-11 mRNA, and that endogenous 
PGE:! appeared to act as an autocrine stimulus for IL-la 
and TGF-P-induced IL-1 1 production by lung fibroblasts. 
The lung is constantly exposed to various environmental 
stimuli, including micro-organisms and chemical com- 
pounds. Alveolar macrophages, mast cells and eosinophils 
stimulated with external and endogenous stimuli release 
many cytokines and arachidonic acid metabolites including 
IL- 1, TGF and PGE2. IL- 11 production by lung ‘ribroblasts 
is regulated by these molecules. It is important to examine 
the IL-1 1 production and regulation mechanisms in normal 
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human lung tissue in order to clarify the pathogenesis of the 
inflamation process. 
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